论文部分内容阅读
AIM To study the effect of ketoconazole (KTZ), a selective inhibitor of CYP3A, on in vivo and in vitro metabolic activity of hepatic CYP3A in rat with midazolam (MDZ) as probe, which was assessed by pharmacokinetic parameters of MDZ., and to establish a s